Cash flow Neurocrine Biosciences, Inc.

Equities

NBIX

US64125C1099

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 01:30:00 14/03/2026 am IST			5-day change	1st Jan Change
129.78 ^USD	+1.57%		+1.29%	-8.50%

09/03	Neurocrine Biosciences, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-09-2026 08:40 AM
04/03	Neurocrine Biosciences, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 11:50 AM

204998eb9633619acb7c52123546d9.HYo9-b6ATdfu2n8uT9ZutFc7WdAPEE0zkd9dfGTKLGg.U-B4wMT1OJy9jz1ALJwa1wBUIZNOcRh69O8bBh6kbwFI60mw2bQXj5fvSw

Published financial data: NEUROCRINE BIOSCIENCES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	113.35Cr	148.87Cr	188.71Cr	235.53Cr	286.05Cr
Total Revenues	113.35Cr	148.87Cr	188.71Cr	235.53Cr	286.05Cr
Cost of Goods Sold, Total	34Cr	49Cr	60Cr	77Cr	106.78Cr
Gross Profit	79Cr	100.17Cr	128.24Cr	159.02Cr	179.27Cr
Selling General & Admin Expenses, Total	58Cr	75Cr	89Cr	100.72Cr	115.62Cr
R&D Expenses	-	-	-	-	-
Other Operating Expenses, Total	58Cr	75Cr	89Cr	100.72Cr	115.62Cr
Operating Income	21Cr	25Cr	39Cr	58Cr	64Cr
Interest Expense, Total	-2.58Cr	-71L	-46L	-	-
Interest And Investment Income	38L	1.12Cr	5.74Cr	9.1Cr	9.03Cr
Net Interest Expenses	-2.2Cr	41L	5.28Cr	9.1Cr	9.03Cr
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	19Cr	25Cr	45Cr	67Cr	73Cr
Gain (Loss) On Sale Of Investments	2.09Cr	3.08Cr	2.84Cr	-3.71Cr	-40L
Gain (Loss) On Sale Of Assets	-	-	-	-	-
In Process R&D Expenses	-11Cr	-	-14Cr	-1.25Cr	-1.74Cr
Other Unusual Items	-	-7Cr	-	-14Cr	-
EBT, Incl. Unusual Items	10Cr	21Cr	33Cr	49Cr	71Cr
Income Tax Expense	1.18Cr	5.94Cr	8.24Cr	14Cr	23Cr
Earnings From Continuing Operations	8.96Cr	15Cr	25Cr	34Cr	48Cr
Net Income to Company	8.96Cr	15Cr	25Cr	34Cr	48Cr
Net Income - (IS)	8.96Cr	15Cr	25Cr	34Cr	48Cr
Net Income to Common Incl Extra Items	8.96Cr	15Cr	25Cr	34Cr	48Cr
Net Income to Common Excl. Extra Items	8.96Cr	15Cr	25Cr	34Cr	48Cr
Per Share Items
Net EPS - Basic	0.95	1.61	2.56	3.4	4.81
Basic EPS - Continuing Operations	0.95	1.61	2.56	3.4	4.81
Basic Weighted Average Shares Outstanding	9.46Cr	9.58Cr	9.77Cr	10Cr	9.95Cr
Net EPS - Diluted	0.92	1.56	2.47	3.29	4.67
Diluted EPS - Continuing Operations	0.92	1.56	2.47	3.29	4.67
Diluted Weighted Average Shares Outstanding	9.79Cr	9.89Cr	10Cr	10Cr	10Cr
Normalized Basic EPS	1.23	1.65	2.86	4.2	4.57
Normalized Diluted EPS	1.19	1.6	2.77	4.06	4.43
American Depositary Receipts Ratio (ADR)	0.05	0.05	0.05	0.05	0.05
Supplemental Items
EBITDA	22Cr	26Cr	42Cr	61Cr	67Cr
EBITA	21Cr	25Cr	40Cr	59Cr	64Cr
EBIT	21Cr	25Cr	39Cr	58Cr	64Cr
EBITDAR	23Cr	28Cr	43Cr	65Cr	73Cr
Total Revenues (As Reported)	113.35Cr	148.87Cr	188.71Cr	235.53Cr	286.05Cr
Effective Tax Rate - (Ratio)	11.64	27.77	24.81	29.77	32.15
Current Domestic Taxes	63L	3.74Cr	14Cr	27Cr	11Cr
Current Foreign Taxes	-	-	-	-	-4.38Cr
Total Current Taxes	63L	3.74Cr	14Cr	27Cr	6.26Cr
Deferred Domestic Taxes	55L	2.2Cr	-5.07Cr	-12Cr	14Cr
Deferred Foreign Taxes	-	-	-	-	1.98Cr
Total Deferred Taxes	55L	2.2Cr	-5.07Cr	-12Cr	16Cr
Normalized Net Income	12Cr	16Cr	28Cr	42Cr	45Cr
Interest on Long-Term Debt	-	-	46L	-	-
Supplemental Operating Expense Items
Advertising Expense	14Cr	15Cr	16Cr	19Cr	23Cr
Selling and Marketing Expenses	-	-	-	19Cr	23Cr
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	43Cr	46Cr	71Cr	74Cr	103.31Cr
Net Rental Expense, Total	1.53Cr	1.63Cr	1.64Cr	4.16Cr	6.11Cr
Imputed Operating Lease Interest Expense	72.66L	25.69L	16.69L	-	-
Imputed Operating Lease Depreciation	80.34L	1.37Cr	1.47Cr	-	-
Stock-Based Comp., COGS (Total)	4.84Cr	5.77Cr	6.8Cr	6.88Cr	9.1Cr
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	8.58Cr	12Cr	13Cr	13Cr	13Cr
Total Stock-Based Compensation	13Cr	17Cr	19Cr	20Cr	22Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	34Cr	26Cr	25Cr	23Cr	71Cr
Short Term Investments	37Cr	73Cr	78Cr	84Cr	77Cr
Total Cash And Short Term Investments	71Cr	99Cr	103.16Cr	107.61Cr	148.04Cr
Accounts Receivable, Total	19Cr	35Cr	44Cr	48Cr	69Cr
Total Receivables	19Cr	35Cr	44Cr	48Cr	69Cr
Inventory	3.05Cr	3.51Cr	3.83Cr	5.74Cr	6.9Cr
Prepaid Expenses	-	-	-	-	17Cr
Other Current Assets, Total	4.55Cr	7.91Cr	9.78Cr	11Cr	12Cr
Total Current Assets	97Cr	145.35Cr	160.7Cr	172.47Cr	252.27Cr
Gross Property Plant And Equipment	21Cr	21Cr	43Cr	70Cr	66Cr
Accumulated Depreciation	-5.19Cr	-6.63Cr	-8.3Cr	-11Cr	-12Cr
Net Property Plant And Equipment	16Cr	15Cr	35Cr	59Cr	55Cr
Long-term Investments	62Cr	40Cr	85Cr	86Cr	118.38Cr
Goodwill	-	-	58L	57L	-
Other Intangibles, Total	-	3.72Cr	3.55Cr	3.65Cr	-
Deferred Tax Assets Long-Term	32Cr	31Cr	36Cr	49Cr	32Cr
Other Long-Term Assets, Total	44L	2.5Cr	4.38Cr	98L	5.95Cr
Total Assets	207.25Cr	236.87Cr	325.14Cr	371.87Cr	463.15Cr
Liabilities
Accounts Payable, Total	5.15Cr	7.63Cr	11Cr	11Cr	10Cr
Accrued Expenses, Total	11Cr	14Cr	32Cr	35Cr	50Cr
Current Portion of Long-Term Debt	-	17Cr	17Cr	-	-
Current Portion of Leases	1.65Cr	1.74Cr	3.2Cr	4.06Cr	5.6Cr
Current Income Taxes Payable	-	-	2.44Cr	-	6.8Cr
Unearned Revenue Current, Total	6.27Cr	13Cr	-	-	-
Other Current Liabilities	35L	33L	39L	55L	1.31Cr
Total Current Liabilities	25Cr	54Cr	65Cr	51Cr	74Cr
Long-Term Debt	34Cr	-	-	-	-
Long-Term Leases	11Cr	9.35Cr	26Cr	46Cr	42Cr
Unearned Revenue Non Current	-	-	-	-	-
Other Non Current Liabilities	1.23Cr	2.97Cr	11Cr	17Cr	22Cr
Total Liabilities	70Cr	66Cr	101.94Cr	112.9Cr	137.84Cr
Common Stock, Total	1L	1L	1L	1L	1L
Additional Paid In Capital	201.14Cr	212.24Cr	238.2Cr	255.46Cr	279.22Cr
Retained Earnings	-64Cr	-41Cr	-16Cr	2.92Cr	45Cr
Comprehensive Income and Other	-17L	-79L	70L	58L	1.31Cr
Total Common Equity	137.4Cr	170.78Cr	223.2Cr	258.97Cr	325.31Cr
Total Equity	137.4Cr	170.78Cr	223.2Cr	258.97Cr	325.31Cr
Total Liabilities And Equity	207.25Cr	236.87Cr	325.14Cr	371.87Cr	463.15Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	9.52Cr	9.66Cr	9.95Cr	9.97Cr	10Cr
ECS Total Common Shares Outstanding	9.49Cr	9.65Cr	9.87Cr	9.94Cr	10Cr
Book Value / Share	14.48	17.7	22.61	26.05	32.5
Tangible Book Value	137.4Cr	167.06Cr	219.07Cr	254.75Cr	325.31Cr
Tangible Book Value Per Share	14.48	17.31	22.2	25.63	32.5
Total Debt	46Cr	28Cr	46Cr	50Cr	47Cr
Net Debt	-25Cr	-71Cr	-57Cr	-58Cr	-100.91Cr
Debt Equivalent Oper. Leases	12Cr	13Cr	13Cr	33Cr	49Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.12Cr	1.2Cr	2.15Cr	3.37Cr	3.57Cr
Inventories - Work In Process, Total	36L	56L	97L	1.09Cr	1.92Cr
Inventories - Finished Goods, Total	1.57Cr	1.75Cr	1.23Cr	1.28Cr	1.43Cr
Machinery, Total	7.56Cr	8.7Cr	12Cr	15Cr	17Cr
Full Time Employees	900	1.2T	1.4T	1.8T	2T

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	8.96Cr	15Cr	25Cr	34Cr	48Cr
Depreciation & Amortization - CF	1.09Cr	1.51Cr	1.78Cr	2.35Cr	2.6Cr
Amortization of Goodwill and Intangible Assets - (CF)	-	5L	35L	36L	41L
Depreciation & Amortization, Total	1.09Cr	1.56Cr	2.13Cr	2.71Cr	3.01Cr
Amortization of Deferred Charges, Total - (CF)	1.73Cr	12L	7L	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-2.09Cr	-3.08Cr	-4.67Cr	1.09Cr	-87L
Asset Writedown & Restructuring Costs	-	-	-	-	7L
Stock-Based Compensation (CF)	13Cr	17Cr	19Cr	20Cr	22Cr
Other Operating Activities, Total	87L	9.32Cr	-5.76Cr	3.98Cr	19Cr
Change In Accounts Receivable	-2.84Cr	-16Cr	-8.93Cr	-3.98Cr	-21Cr
Change In Inventories	-25L	-26L	54L	-1.91Cr	-1.53Cr
Change In Accounts Payable	5.68Cr	11Cr	6.43Cr	2.9Cr	16Cr
Change In Income Taxes	-	-	-	-	-1.88Cr
Change in Other Net Operating Assets	-92L	-1.72Cr	4.78Cr	1.07Cr	-4.44Cr
Cash from Operations	26Cr	34Cr	39Cr	60Cr	78Cr
Capital Expenditure	-2.34Cr	-1.65Cr	-2.83Cr	-3.82Cr	-3.4Cr
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-4.27Cr	-	-	-
Investment in Marketable and Equity Securities, Total	-10Cr	-11Cr	-44Cr	-8.86Cr	-23Cr
Other Investing Activities, Total	-46L	-77L	-	-	-
Cash from Investing	-13Cr	-18Cr	-47Cr	-13Cr	-26Cr
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-1L	-28Cr	-	-31Cr	-
Total Debt Repaid	-1L	-28Cr	-	-31Cr	-
Issuance of Common Stock	2.75Cr	4.47Cr	6.53Cr	12Cr	13Cr
Repurchase of Common Stock	-	-	-	-30Cr	-17Cr
Cash from Financing	2.74Cr	-23Cr	6.53Cr	-49Cr	-3.83Cr
Foreign Exchange Rate Adjustments	-	-13L	3L	-	-
Net Change in Cash	15Cr	-7.33Cr	-1.16Cr	-1.81Cr	48Cr
Supplemental Items
Cash Interest Paid	86L	66L	38L	16L	-
Cash Income Tax Paid (Refund)	51L	1.44Cr	5.15Cr	22Cr	8.14Cr
Levered Free Cash Flow	25Cr	23Cr	41Cr	46Cr	40Cr
Unlevered Free Cash Flow	25Cr	23Cr	41Cr	46Cr	40Cr
Change In Net Working Capital	35L	9.76Cr	2.68Cr	9.08Cr	21Cr
Net Debt Issued / Repaid	-1L	-28Cr	-	-31Cr	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.82	7.01	8.78	10.46	9.53
Return on Total Capital	7.71	8.19	10.58	12.68	11.75
Return On Equity %	7.17	10.03	12.68	14.16	16.38
Return on Common Equity	7.17	10.03	12.68	14.16	16.38
Margin Analysis
Gross Profit Margin %	69.79	67.29	67.96	67.52	62.67
SG&A Margin	51.46	50.56	47.04	42.76	40.42
EBITDA Margin %	19.29	17.77	22.05	25.9	23.3
EBITA Margin %	18.33	16.76	21.11	24.91	22.39
EBIT Margin %	18.33	16.73	20.92	24.75	22.25
Income From Continuing Operations Margin %	7.9	10.38	13.23	14.49	16.73
Net Income Margin %	7.9	10.38	13.23	14.49	16.73
Net Avail. For Common Margin %	7.9	10.38	13.23	14.49	16.73
Normalized Net Income Margin	10.24	10.63	14.82	17.89	15.88
Levered Free Cash Flow Margin	21.99	15.25	21.47	19.44	13.91
Unlevered Free Cash Flow Margin	21.89	15.46	21.58	19.44	13.91
Asset Turnover
Asset Turnover	0.6	0.67	0.67	0.68	0.69
Fixed Assets Turnover	8	9.88	7.66	5.02	5.03
Receivables Turnover (Average Receivables)	6.62	5.56	4.78	5.13	4.91
Inventory Turnover (Average Inventory)	11.71	14.85	16.48	15.99	16.9
Short Term Liquidity
Current Ratio	3.96	2.7	2.45	3.4	3.39
Quick Ratio	3.65	2.49	2.25	3.06	2.92
Operating Cash Flow to Current Liabilities	1.04	0.63	0.6	1.17	1.05
Days Sales Outstanding (Average Receivables)	55.16	65.65	76.33	71.36	74.38
Days Outstanding Inventory (Average Inventory)	31.18	24.58	22.15	22.89	21.6
Average Days Payable Outstanding	48.1	47.44	52.9	56.78	34.63
Cash Conversion Cycle (Average Days)	38.24	42.79	45.59	37.47	61.36
Long Term Solvency
Total Debt/Equity	33.25	16.41	20.63	19.14	14.49
Total Debt / Total Capital	24.95	14.1	17.1	16.07	12.65
LT Debt/Equity	32.05	5.47	11.57	17.57	12.77
Long-Term Debt / Total Capital	24.05	4.7	9.59	14.75	11.15
Total Liabilities / Total Assets	33.7	27.9	31.35	30.36	29.76
EBIT / Interest Expense	8.05	35.07	85.83	-	-
EBITDA / Interest Expense	9.07	39.56	94.02	-	-
(EBITDA - Capex) / Interest Expense	8.16	37.24	87.87	-	-
Total Debt / EBITDA	1.95	1	1.06	0.76	0.65
Net Debt / EBITDA	-1.09	-2.52	-1.32	-0.89	-1.39
Total Debt / (EBITDA - Capex)	2.17	1.06	1.14	0.81	0.68
Net Debt / (EBITDA - Capex)	-1.21	-2.68	-1.41	-0.95	-1.45
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.38	31.34	26.76	24.81	21.45
Gross Profit, 1 Yr. Growth %	3.98	26.62	28.02	24	12.73
EBITDA, 1 Yr. Growth %	-34.93	20.99	57.26	46.62	6.81
EBITA, 1 Yr. Growth %	-36.55	20.07	59.64	47.28	6.66
EBIT, 1 Yr. Growth %	-36.55	19.83	58.55	47.67	6.62
Earnings From Cont. Operations, 1 Yr. Growth %	-78	72.43	61.62	36.68	40.23
Net Income, 1 Yr. Growth %	-78	72.43	61.62	36.68	40.23
Normalized Net Income, 1 Yr. Growth %	-39.54	36.22	76.85	50.58	5.64
Diluted EPS Before Extra, 1 Yr. Growth %	-77.88	69.57	58.33	33.2	41.95
Accounts Receivable, 1 Yr. Growth %	18.08	88.68	25.51	9.06	43.35
Inventory, 1 Yr. Growth %	8.93	15.08	9.12	49.87	20.21
Net Property, Plant and Equip., 1 Yr. Growth %	22.29	-6.55	138.53	70.46	-7.91
Total Assets, 1 Yr. Growth %	19.47	14.29	37.27	14.37	24.55
Tangible Book Value, 1 Yr. Growth %	22	21.59	31.56	16.29	25.62
Common Equity, 1 Yr. Growth %	22	24.29	30.69	16.03	25.62
Cash From Operations, 1 Yr. Growth %	12.25	32.32	14.88	52.71	31.46
Capital Expenditures, 1 Yr. Growth %	114.68	-29.49	71.52	34.98	-10.99
Levered Free Cash Flow, 1 Yr. Growth %	-10.53	-14.59	65.75	4.26	-21.59
Unlevered Free Cash Flow, 1 Yr. Growth %	-10.66	-12.98	64.46	4.26	-21.59
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	19.93	19.3	29.03	25.78	23.12
Gross Profit, 2 Yr. CAGR %	16.72	14.74	27.32	26	18.23
EBITDA, 2 Yr. CAGR %	-3.32	-11.27	37.94	51.85	26.57
EBITA, 2 Yr. CAGR %	-4.24	-12.72	38.45	53.33	26.82
EBIT, 2 Yr. CAGR %	-4.24	-12.8	37.84	53.02	26.97
Earnings From Cont. Operations, 2 Yr. CAGR %	55.62	-38.41	66.94	48.63	38.44
Net Income, 2 Yr. CAGR %	55.62	-38.41	66.94	48.63	38.44
Normalized Net Income, 2 Yr. CAGR %	-6.78	-9.25	55.21	63.19	27.43
Diluted EPS Before Extra, 2 Yr. CAGR %	53.59	-38.76	63.85	45.22	37.5
Accounts Receivable, 2 Yr. CAGR %	21.05	49.26	53.89	17	25.04
Inventory, 2 Yr. CAGR %	32.78	11.96	12.06	27.88	34.22
Net Property, Plant and Equip., 2 Yr. CAGR %	15.79	6.9	49.3	101.64	25.29
Total Assets, 2 Yr. CAGR %	25.97	16.85	25.25	25.3	19.35
Tangible Book Value, 2 Yr. CAGR %	46.88	21.79	26.27	23.69	21.86
Common Equity, 2 Yr. CAGR %	46.88	23.14	27.45	23.14	20.73
Cash From Operations, 2 Yr. CAGR %	32.09	21.87	23.29	32.45	41.68
Capital Expenditures, 2 Yr. CAGR %	26.17	23.04	9.97	52.16	9.61
Levered Free Cash Flow, 2 Yr. CAGR %	10.39	-9.73	23.46	36	-4.83
Unlevered Free Cash Flow, 2 Yr. CAGR %	10.21	-8.95	24.07	36	-4.83
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	35.94	23.62	21.74	27.61	24.32
Gross Profit, 3 Yr. CAGR %	39.65	19.93	19.01	26.2	21.41
EBITDA, 3 Yr. CAGR %	68.64	4.18	7.38	40.77	36.07
EBITA, 3 Yr. CAGR %	70.94	3.26	6.74	41.33	36.93
EBIT, 3 Yr. CAGR %	70.94	3.19	6.43	41.04	36.73
Earnings From Cont. Operations, 3 Yr. CAGR %	61.94	61.03	-15.05	56.17	45.77
Net Income, 3 Yr. CAGR %	61.94	61.03	-15.05	56.17	45.77
Normalized Net Income, 3 Yr. CAGR %	91.16	5.79	13.36	53.65	42.14
Diluted EPS Before Extra, 3 Yr. CAGR %	61.11	58.74	-15.95	52.92	44.12
Accounts Receivable, 3 Yr. CAGR %	47.84	40.35	40.88	37.2	25.2
Inventory, 3 Yr. CAGR %	41.07	26.6	11.01	23.46	25.27
Net Property, Plant and Equip., 3 Yr. CAGR %	66.31	7.81	39.69	56.05	55.29
Total Assets, 3 Yr. CAGR %	27.79	21.95	23.3	21.52	25.05
Tangible Book Value, 3 Yr. CAGR %	41.91	37.91	24.83	22.85	25.01
Common Equity, 3 Yr. CAGR %	41.91	38.93	25.61	23.52	23.96
Cash From Operations, 3 Yr. CAGR %	36.25	32.17	19.5	32.41	32.12
Capital Expenditures, 3 Yr. CAGR %	-1.92	3.93	37.44	17.75	27.25
Levered Free Cash Flow, 3 Yr. CAGR %	71.9	3.53	13.29	19.89	17.12
Unlevered Free Cash Flow, 3 Yr. CAGR %	71.44	4.07	13.61	20.07	17.12
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	137.5	55.9	33.13	24.48	22.29
Gross Profit, 5 Yr. CAGR %	106.83	70.98	34.58	22.32	18.7
EBITDA, 5 Yr. CAGR %	8.43	21.74	55.61	21.13	14.68
EBITA, 5 Yr. CAGR %	7.11	19.74	57.12	20.95	14.36
EBIT, 5 Yr. CAGR %	7.11	19.69	56.84	20.8	14.21
Earnings From Cont. Operations, 5 Yr. CAGR %	-8.68	1.62	63.92	55.95	3.28
Net Income, 5 Yr. CAGR %	-8.68	1.62	63.92	55.95	3.28
Normalized Net Income, 5 Yr. CAGR %	6.2	17.6	75.87	25.81	18.79
Diluted EPS Before Extra, 5 Yr. CAGR %	-10.81	-0.75	62.2	53.19	2.34
Accounts Receivable, 5 Yr. CAGR %	-	62.25	50.23	30.5	34.32
Inventory, 5 Yr. CAGR %	-	102.77	28.66	27.11	19.77
Net Property, Plant and Equip., 5 Yr. CAGR %	90.13	68.21	59.29	38.49	33.74
Total Assets, 5 Yr. CAGR %	41.52	23.71	26.77	23.28	21.7
Tangible Book Value, 5 Yr. CAGR %	34.27	35.03	35.43	31.95	23.63
Common Equity, 5 Yr. CAGR %	34.27	35.63	35.94	32.38	23.63
Cash From Operations, 5 Yr. CAGR %	19.29	29.18	30.91	32.28	27.92
Capital Expenditures, 5 Yr. CAGR %	41.62	18.91	2.68	21.05	25.55
Levered Free Cash Flow, 5 Yr. CAGR %	33.04	43.22	52.53	17.49	7.38
Unlevered Free Cash Flow, 5 Yr. CAGR %	32.91	43.94	52.59	17.53	7.45